Low
₹19.34
High
₹19.88
| Previous Close | ₹19.45 |
|---|---|
| Day's Range | ₹19.34 - ₹19.88 |
| Open | ₹19.88 |
| 52 Week Range | ₹14.55 - ₹20.39 |
| Volume | 1,77,306 |
| Market Cap |
| Trade Value ( ₹ in Lacs) | 34.53 |
|---|---|
| Market Cap (₹ in Mn) | |
| Dividend Yield(%) | |
| Price/Earning (TTM) | |
| TTM EPS (₹) | |
| P/E Ratio | |
| Book Value(₹) | |
| PAT Margin (%) | |
| Face Value (₹) | |
| ROCE(%) |
| NSE Symbol | MIDSELIETF |
|---|
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|
No Records Found
ICICI Prudential Asset Management Company has informed about Intimation regarding proposed sale of equity shares of the company by one of the promoters, Prudential Corporation Holdings Limited, to divest a part of its shareholding in the open market for complying with minimum public shareholding.
The above information is a part of company’s filings submitted to BSE.
In continuation to letter dated November 14, 2026, intimating approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, and pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panacea Biotec has informed that it enclosed newspaper copies of the Extract of Statement of aforesaid Unaudited Financial Results published in the newspapers, Business Standard (English) and Desh Sewak (Punjabi) on November 16, 2026.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended, INDO-MIM has informed that the officials of the Company will be attending the meeting with Analysts/ Investors (Participants). The particulars of these meetings are enclosed. Discussions will be based on publicly available information and no unpublished price sensitive information (‘UPSI’) is intended to be discussed and shared during the interactions/meeting. Also enclosed the Investor Presentation for the said Analyst meet. The same will be available on the website of the Company at www.indo-mim.com.
No Records Found
The current share price of ICICI Prudential BSE Midcap Select ETF is ₹19.45 as of 2026-11-16.
The market capitalisation of ICICI Prudential BSE Midcap Select ETF is ₹ as of .
The 1-year return of ICICI Prudential BSE Midcap Select ETF is 0.90% as of 2026-11-16.
The P/E ratio of ICICI Prudential BSE Midcap Select ETF is as of .
The 52-week high and low of ICICI Prudential BSE Midcap Select ETF are ₹ and ₹, respectively, as of 2026-11-16.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.